BCL2 and cancer: In line with anti-cancer effects, SSE attenuated apoptosis resistance in VSMCs, as evidenced by growth in the number of TUNEL positive cells and the expression of pro-apoptosis markers Bax/Bcl-2 and Cleaved Caspase-3.